IL-1 receptor antagonist

This page covers all IL-1 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-1 receptor type I (IL-1RI), IL-1 receptor type I, IL1R1.

Targets

IL-1 receptor type I (IL-1RI) · IL-1 receptor type I · IL1R1

Marketed (1)

• Anakinra (r-metHuIL-1ra) · Amgen · Immunology
  Anakinra is a recombinant interleukin-1 receptor antagonist that blocks IL-1 signaling to reduce inflammation.

Phase 3 pipeline (1)

• Anakinra (Kineret®) · Monash Medical Centre · Immunology
  Anakinra blocks interleukin-1 (IL-1) receptor signaling to reduce inflammatory cytokine activity.

Phase 2 pipeline (1)

• AMG 301 · Amgen · Oncology
  AMG 301 is a monoclonal antibody targeting the interleukin-1 receptor type 1 (IL1R1).

Patent intelligence

• il 1 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates